Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVSA
CVSA logo

CVSA Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
133.740
Open
121.990
VWAP
129.62
Vol
703.00K
Mkt Cap
4.55B
Low
121.400
Amount
91.13M
EV/EBITDA(TTM)
--
Total Shares
34.03M
EV
4.90B
EV/OCF(TTM)
12.07
P/S(TTM)
2.55
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
Show More

Events Timeline

(ET)
2026-05-07
16:40:00
Raises FY Revenue Outlook to $1.93B-$1.945B
select
2026-05-07
16:40:00
Covista Reports Q3 Revenue of $487.03M, Exceeds Expectations
select
2026-04-23 (ET)
2026-04-23
08:10:00
Covista Announces 97% First-Time Residency Rate for 2025-2026 Graduates
select
2026-04-13 (ET)
2026-04-13
08:20:00
Covista Appoints Amelia Manning as President of Chamberlain University
select
2026-04-06 (ET)
2026-04-06
08:10:00
Covista Appoints Michael Betz as Chief Growth & Innovation Officer
select

News

Fool
9.5
14:06 PMFool
MNDY Surges on AI-Driven Efficiency Gain
  • Earnings Beat: monday.com (MNDY) reported Q1 revenue of $351.3 million, a 24% year-over-year increase that exceeded analyst expectations, showcasing the company's strong performance and growth potential in the market.
  • Strategic Shift: Leadership highlighted the transition to consumption-based pricing and the successful rollout of its AI Work Platform as key drivers, which not only enhanced customer satisfaction but also strengthened competitive positioning in the market.
  • Operational Leverage: CFO Eliran Glazer noted that internal AI productivity gains allow the company to scale revenue without increasing headcount, indicating a higher operational efficiency achieved in a complex environment.
  • Strong Cash Flow: The firm generated over $102 million in adjusted free cash flow, providing substantial capital to further invest in autonomous AI agents, thereby enhancing the sustainability of future growth.
seekingalpha
9.5
05-08seekingalpha
Covista Reports Strong Quarterly Results and Raises Annual Guidance
  • Student Enrollment Growth: Covista's total student enrollment reached 100,585 for the quarter, reflecting a 6.8% year-over-year increase, surpassing expectations and indicating the effectiveness of the company's operational model, with Q4 expected to maintain this growth momentum into the fall enrollment cycle.
  • Revenue Guidance Increase: The company raised its FY26 revenue guidance from a range of $1.9 billion to $1.94 billion to a new range of $1.93 billion to $1.945 billion, projecting nearly 8% to 9% year-over-year growth, reflecting optimistic expectations for future market demand.
  • Adjusted EPS Improvement: Covista increased its adjusted earnings per share guidance from a previous range of $7.80 to $8.00 to a new range of $7.95 to $8.15, demonstrating enhanced profitability and boosting investor confidence.
  • Q3 Performance Exceeds Expectations: The company reported third-quarter revenue of $487 million, a 4.5% year-over-year increase, beating market estimates by $13.01 million, with adjusted EPS of $1.98 exceeding consensus by $0.26, showcasing strong performance in a competitive education market.
seekingalpha
9.5
05-08seekingalpha
Covista Q3 Earnings: Rebranding and Growth Insights
  • Strong Performance: Covista reported a 4.5% year-over-year revenue increase to $487 million in Q3, with an adjusted growth of 8.4% when excluding academic calendar shifts, highlighting robust demand and adaptability in the healthcare sector.
  • Enrollment Milestone: The company surpassed 100,000 registered students, with Walden achieving a 12.3% increase to over 54,000 students, indicating the effectiveness of its educational model and growing market appeal.
  • Guidance Upgrade: CFO Phelan raised full-year revenue guidance to a range of $1.93 billion to $1.945 billion and adjusted EPS guidance to $7.95 to $8.15, reflecting strong confidence in future growth prospects.
  • Ongoing Strategic Investments: The company plans to continue strategic investments in Q4, including the development of six new campuses and a new brand campaign, aimed at further enhancing market share and brand influence.
Newsfilter
9.5
05-07Newsfilter
Covista Reports Significant Growth in Q3 Performance
  • Total Enrollment Growth: Covista's total student enrollment reached 100,585, marking a 6.8% year-over-year increase, with both Chamberlain and Walden universities achieving record highs, indicating strong momentum in the higher education sector.
  • Significant Revenue Increase: The company reported third-quarter revenue of $487 million, up 4.5% year-over-year, and an 8.4% increase when adjusted for Walden's one-week academic shift, reflecting robust performance and improved profitability in the education market.
  • Optimized Capital Allocation: In the third quarter, Covista repurchased $66 million in shares and successfully refinanced its debt into a $510 million Term Loan B, extending maturity to 2033, resulting in a net leverage ratio of 0.7x, enhancing financial flexibility.
  • Positive Future Outlook: Covista raised its fiscal year 2026 revenue guidance to $1.93 billion to $1.945 billion, anticipating 8% to 9% year-over-year growth, while also increasing adjusted earnings per share expectations to $7.95 to $8.15, demonstrating confidence in future growth prospects.
Newsfilter
8.5
04-14Newsfilter
Covista Launches Healthcare AI Credentials and Future Classroom Development
  • Healthcare AI Credentials Live: Covista's healthcare AI credentials, launched in collaboration with Google Cloud, are now available across five institutions, attracting over 3,400 students in the first week, indicating a strong demand for AI fluency in the healthcare sector, which is expected to enhance graduates' competitiveness in the job market.
  • Future Classroom Development: Covista is developing an AI-powered future classroom aimed at enhancing educational quality through personalized learning experiences, integrating tools like LearnLM, Gemini, and NotebookLM, with a pilot expected later this year to transform educational methodologies.
  • Advisory Council of Industry Leaders: Covista has established the Healthcare AI Readiness Council, bringing together healthcare executives and technology innovators to guide curriculum design, ensuring that AI innovations are closely aligned with clinical practice, thereby producing graduates equipped with essential AI skills.
  • Flexible Curriculum Design: The newly launched AI certificate programs are accessible not only to current students but also to alumni and healthcare professionals, with flexible coursework tailored to the schedules of working clinicians, helping them master AI applications in clinical settings to improve patient care quality.
NASDAQ.COM
5.0
03-12NASDAQ.COM
Insider Buying Analysis: Alpha Metallurgical and Covista
  • Insider Trading Activity: Director Kenneth S. Courtis of Alpha Metallurgical Resources purchased 25,000 shares of AMR on Monday at $176.23 each, totaling an investment of $4.41 million, indicating confidence in the company's future performance.
  • Return on Investment: At today's trading high, Courtis's investment saw an 11.9% return, with AMR reaching a peak price of $197.21, reflecting a positive market response to the stock.
  • Historical Purchase Record: Over the past 12 months, Courtis has made four additional purchases of AMR shares, totaling $30.74 million at an average cost of $161.79 per share, demonstrating his sustained optimism about the company's long-term prospects.
  • Covista Trading Activity: Director Michael W. Malafronte of Covista bought 36,036 shares on Wednesday at $100.88 each, amounting to a total investment of $3.64 million, with the stock currently up 0.8%, indicating market approval of his investment.
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
Wall Street analysts forecast CVSA stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
Truist
Buy
initiated
$130
AI Analysis
2026-03-24
Reason
Truist
Price Target
$130
AI Analysis
2026-03-24
initiated
Buy
Reason
Truist initiated coverage of Covista, formerly Adtalem, with a Buy rating and $130 price target. The company's clinical healthcare-focused institutions should benefit from labor shortages and upskilling trends, the analyst tells investors in a research note. Truist sees a "favorable catalyst path" for the shares in the coming months, saying Covista's mix towards clinical fields are largely insulated from AI disruption. In addition, early indications Chamberlain starts "could turn the corner," contends Truist.

Valuation Metrics

The current forward P/E ratio for Covista Inc (CVSA.N) is 13.42, compared to its 5-year average forward P/E of 15.07. For a more detailed relative valuation and DCF analysis to assess Covista Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
15.07
Current PE
13.42
Overvalued PE
17.16
Undervalued PE
12.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.59
Current EV/EBITDA
8.40
Overvalued EV/EBITDA
8.94
Undervalued EV/EBITDA
8.25

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.90
Current PS
1.97
Overvalued PS
2.04
Undervalued PS
1.76

Financials

AI Analysis
Annual
Quarterly

Whales Holding CVSA

Ö
ÖKoworld Lux S.A.
Holding
CVSA
+5.05%
3M Return
A
Ariel Investments, LLC
Holding
CVSA
-1.99%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Covista Inc (CVSA) stock price today?

The current price of CVSA is 133.73 USD — it has increased 14.3

What is Covista Inc (CVSA)'s business?

Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.

What is the price predicton of CVSA Stock?

Wall Street analysts forecast CVSA stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVSA is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Covista Inc (CVSA)'s revenue for the last quarter?

Covista Inc revenue for the last quarter amounts to 487.03M USD, increased 4.50

What is Covista Inc (CVSA)'s earnings per share (EPS) for the last quarter?

Covista Inc. EPS for the last quarter amounts to 1.20 USD, decreased -24.53

How many employees does Covista Inc (CVSA). have?

Covista Inc (CVSA) has 4703 emplpoyees as of May 11 2026.

What is Covista Inc (CVSA) market cap?

Today CVSA has the market capitalization of 4.55B USD.